During the past decade, University Hospital Brussels conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 10 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Brussels" #1 sponsor was "Universitair Ziekenhuis Brussel" with 6 trials, followed by "PTC Therapeutics" with 5 trials sponsored, "Celgene" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "AZ-VUB" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Brussels" #1 collaborator was "Cystic Fibrosis Foundation" with 3 trials as a collaborator, "Universitair Ziekenhuis Brussel" with 3 trials as a collaborator, "GE Healthcare" with 2 trials as a collaborator, "HeartFlow, Inc." with 2 trials as a collaborator and "University Hospital, Ghent" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Brussels" are "Cystic Fibrosis" (5 trials), "Crohn Disease" (3 trials), "Dermatitis, Atopic" (2 trials), "Endothelial Dysfunction" (2 trials) and "Abdominal Aortic Aneurysms (AAA)" (1 trials). Many other conditions were trialed in "University Hospital Brussels" in a lesser frequency.

Most popular intervention types in "University Hospital Brussels" are "Drug" (27 trials), "Other" (10 trials), "Biological" (4 trials), "Device" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ataluren" (4 trials), "Ozanimod" (3 trials), "Blood sample" (2 trials) and "6-tioguanine+Standard Maintenance Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Brussels" are 37 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospital Brussels". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in University Hospital Brussels, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Brussels, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 7 trials that are defined as “Not Applicable".